|
Emergency treatment of Stroke
Citations 351-360 of 820 total displayed.
|
Past content
(since Dec 1999):
|
- Articles
Reduced Pretreatment Ipsilateral Middle Cerebral Artery Cerebral Blood Flow Is Predictive of Symptomatic Hemorrhage Post-Intra-Arterial Thrombolysis in Patients With Middle Cerebral Artery Occlusion
- Rishi Gupta, Howard Yonas, James Gebel, Steven Goldstein, Michael Horowitz, Stephen Z. Grahovac, Lawrence R. Wechsler, Maxim D. Hammer, Ken Uchino, and Tudor G. Jovin
Stroke published September 7, 2006, doi:10.1161/01.STR.0000240687.14265.b4
[Abstract]
- Original Contributions
Role of Fibrinogen Levels and Factor XIII V34L Polymorphism in Thrombolytic Therapy in Stroke Patients
- Rocio González-Conejero, Israel Fernández-Cadenas, Juan A. Iniesta, Joan Marti-Fabregas, Victor Obach, José Alvarez-Sabín, Vicente Vicente, Javier Corral, Joan Montaner for the Proyecto Ictus Research Group
Stroke 2006;37:2288-2293; published online before print as doi:10.1161/01.STR.0000236636.39235.4f
[Abstract]
[Full text]
- Short Communications
Intravenous Tissue Plasminogen Activator in Patients With Stroke Increases the Bioavailability of Insulin-Like Growth Factor-1
- Nadine Wilczak, Jan Willem Elting, Daniel Chesik, Ido P. Kema, and Jacques De Keyser
Stroke 2006;37:2368-2371; published online before print as doi:10.1161/01.STR.0000236496.30106.4b
[Abstract]
[Full text]
- Articles
Discontinuation of Statin Treatment in Stroke Patients
- Matthias Endres and Ulrich Laufs
Stroke published August 31, 2006, doi:10.1161/01.STR.0000240690.69406.28
[Abstract]
- Articles
Feasibility of Acute Clinical Trials During Aerial Interhospital Transfer
- Enrique C. Leira, Diane L. Lamb, Andrew S. Nugent, Azeemuddin Ahmed, Karla J. Grimsman, William R. Clarke, and Harold P. Adams, Jr
Stroke published August 31, 2006, doi:10.1161/01.STR.0000239661.07675.9d
[Abstract]
- Articles
Leukoaraiosis Is a Risk Factor for Symptomatic Intracerebral Hemorrhage After Thrombolysis for Acute Stroke
- Tobias Neumann-Haefelin, Silke Hoelig, Joachim Berkefeld, Jens Fiehler, Achim Gass, Marek Humpich, Andreas Kastrup, Thomas Kucinski, Olivera Lecei, David S. Liebeskind, Joachim Rother, Charlotte Rosso, Yves Samson, Jeffrey L. Saver, Bernhard Yan for the MR Stroke Group
Stroke published August 24, 2006, doi:10.1161/01.STR.0000239321.53203.ea
[Abstract]
- Articles
Intravenous Tissue Plasminogen Activator in Patients With Stroke Increases the Bioavailability of Insulin-Like Growth Factor-1
- Nadine Wilczak, Jan Willem Elting, Daniel Chesik, Ido P. Kema, and Jacques De Keyser
Stroke published August 10, 2006, doi:10.1161/01.STR.0000236496.30106.4b
[Abstract]
- Original Contributions
Lack of Evidence for an Association Between Hemodynamic Variables and Hematoma Growth in Spontaneous Intracerebral Hemorrhage
- Edward C. Jauch, Christopher J. Lindsell, Opeolu Adeoye, Jane Khoury, William Barsan, Joseph Broderick, Arthur Pancioli, and Thomas Brott
Stroke 2006;37:2061-2065; published online before print as doi:10.1161/01.STR.0000229878.93759.a2
[Abstract]
[Full text]
- Articles
Role of Fibrinogen Levels and Factor XIII V34L Polymorphism in Thrombolytic Therapy in Stroke Patients
- Rocio González-Conejero, Israel Fernández-Cadenas, Juan A. Iniesta, Joan Marti-Fabregas, Victor Obach, José Alvarez-Sabín, Vicente Vicente, Javier Corral, Joan Montaner for the Proyecto Ictus Research Group
Stroke published July 20, 2006, doi:10.1161/01.STR.0000236636.39235.4f
[Abstract]
- Original Contributions
Hemostatic Activation and Outcome After Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke
- David Tanne, Richard F. Macko, Yan Lin, Barbara C. Tilley, Steven R. Levine for the NINDS rtPA Stroke Study Group
Stroke 2006;37:1798-1804; published online before print as doi:10.1161/01.STR.0000226897.43749.27
[Abstract]
[Full text]
|
|
